These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 18894851)
21. Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. An J; Sun Y; Fisher M; Rettig MB Leukemia; 2004 Oct; 18(10):1699-704. PubMed ID: 15343345 [TBL] [Abstract][Full Text] [Related]
22. Chemotherapy in relation to dental extractions. PENINGTON GA Aust J Dent; 1947 Nov; 51(6):351-3. PubMed ID: 20272170 [No Abstract] [Full Text] [Related]
23. Recent advances in the chemotherapy of tuberculosis. RIGGINS HM N C Med J; 1947 Nov; 8(11):694-7. PubMed ID: 20271338 [No Abstract] [Full Text] [Related]
24. Energy mechanisms in malignant tumors in relation to chemotherapy. BLACK MM; KLEINER IS; BOLKER H Cancer Res; 1947 Dec; 7(12):818-26. PubMed ID: 18880698 [No Abstract] [Full Text] [Related]
25. Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo. Dicko A; Mayer LD; Tardi PG Expert Opin Drug Deliv; 2010 Dec; 7(12):1329-41. PubMed ID: 21118030 [TBL] [Abstract][Full Text] [Related]
26. Facile preparation of doxorubicin-loaded upconversion@polydopamine nanoplatforms for simultaneous in vivo multimodality imaging and chemophotothermal synergistic therapy. Liu F; He X; Lei Z; Liu L; Zhang J; You H; Zhang H; Wang Z Adv Healthc Mater; 2015 Mar; 4(4):559-68. PubMed ID: 25471617 [TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy of cancer based upon quantitative biochemical differences. SHAPIRO DM Surg Forum; 1955; 5():646-50. PubMed ID: 13247105 [No Abstract] [Full Text] [Related]
28. ["Efficacy Theory" may help to explain characteristic advantages of traditional Chinese medicines]. Cai SQ; Wang X; Shang MY; Xu F; Liu GX Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3435-43. PubMed ID: 26978986 [TBL] [Abstract][Full Text] [Related]
29. Chemotherapy in veterinary medicine. HERDMAN NA; PAISLEY R Chem Drug Export Rev; 1948 Jul; 9(99):57-60. PubMed ID: 18874498 [No Abstract] [Full Text] [Related]
39. [THE RESULTS AND FOLLOW-UP STUDY OF THE AMBULATORY CHEMOTHERAPY IN PULMONARY TUBERCULOSIS. VI. ANALYSIS ON THE FACTORS INFLUENCING THE RADIOLOGICAL AGGRAVATION AFTER THE CESSATION OF CHEMOTHERAPY]. NAKAMURA Y Kekkaku; 1964 Nov; 39():500-4. PubMed ID: 14263536 [No Abstract] [Full Text] [Related]
40. The interplay of immunotherapy and chemotherapy: harnessing potential synergies. Emens LA; Middleton G Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]